Therapeutic peptide vaccines for treatment of autoimmune diseases

Immunology Letters

Volumn 122, Issue 2, 2009, Pages 134-136

  Wraith, David C ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; DEXAMETHASONE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 5; PEPTIDE VACCINE; T LYMPHOCYTE ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; ALLERGEN; AUTOANTIGEN; CYTOKINE; SUBUNIT VACCINE;

ALLERGIC DISEASE; AUTOIMMUNE DISEASE; DENDRITIC CELL; DIABETES MELLITUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; ANAPHYLAXIS; ANIMAL; ANTIGEN PRESENTATION; DESENSITIZATION; HOMEOSTASIS; HYPERSENSITIVITY; IMMUNOLOGY; METABOLISM; PATHOLOGY; T LYMPHOCYTE SUBPOPULATION;

ALLERGENS; ANAPHYLAXIS; ANIMALS; ANTIGEN PRESENTATION; AUTOANTIGENS; AUTOIMMUNE DISEASES; CYTOKINES; DENDRITIC CELLS; DESENSITIZATION, IMMUNOLOGIC; HOMEOSTASIS; HUMANS; HYPERSENSITIVITY; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; VACCINES, SUBUNIT;

EID: 73349086899     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2008.11.013     Document Type: Review

References (17)

1. Wraith D.C., Nicolson K.S., and Whitley N.T. Regulatory CD4+ T cells and the control of autoimmune disease. Curr Opin Immunol 16 (2004) 695-701
2. O'Garra A., Vieira P.L., Vieira P., and Goldfeld A.E. IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J Clin Invest 114 (2004) 1372-1378
3. Wakkach A., Fournier N., Brun V., Breittmayer J.P., Cottrez F., and Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18 (2003) 605-617
4. Menges M., Rossner S., Voigtlander C., Schindler H., Kukutsch N.A., Bogdan C., et al. Repetitive injections of dendritic cells matured with tumor necrosis factor α induce antigen-specific protection of mice from autoimmunity. J Exp Med 195 (2002) 15-21
5. Steinman R.M., Hawiger D., and Nussenzweig M.C. Tolerogenic dendritic cells. Annu Rev Immunol 21 (2003) 685-711
6. Larche M., and Wraith D.C. Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat Med 11 (2005) S69-76
7. Faria A.M., and Weiner H.L. Oral tolerance: mechanisms and therapeutic applications. Adv Immunol 73 (1999) 153-264
8. Anderton S.M., and Wraith D.C. Hierarchy in the ability of T cell epitopes to induce peripheral tolerance to antigens from myelin. Eur J Immunol 28 (1998) 1251-1261
9. O'Neill E.J., Day M.J., and Wraith D.C. IL-10 is essential for disease protection following intranasal peptide administration in the C57BL/6 model of EAE. J Neuroimmunol 178 (2006) 1-8
10. Burkhart C., Liu G.Y., Anderton S.M., Metzler B., and Wraith D.C. Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10. Int Immunol 11 (1999) 1625-1634
11. Sundstedt A., O'Neill E.J., Nicolson K.S., and Wraith D.C. Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo. J Immunol 170 (2003) 1240-1248
12. Vieira P.L., Christensen J.R., Minaee S., O'Neill E.J., Barrat F.J., Boonstra A., et al. IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+ CD25+ regulatory T cells. J Immunol 172 (2004) 5986-5993
13. Nicolson K.S., O'Neill E.J., Sundstedt A., Streeter H.B., Minaee S., and Wraith D.C. Antigen-induced IL-10+ regulatory T cells are independent of CD25+ regulatory cells for their growth, differentiation, and function. J Immunol 176 (2006) 5329-5337
14. Anderson P.O., Manzo B.A., Sundstedt A., Minaee S., Symonds A., Khalid S., et al. Persistent antigenic stimulation alters the transcription program in T cells, resulting in antigen-specific tolerance. Eur J Immunol 36 (2006) 1374-1385
15. Trinchieri G. Interleukin-10 production by effector T cells: Th1 cells show self control. J Exp Med 204 (2007) 239-243
16. Peakman M., Stevens E.J., Lohmann T., Narendran P., Dromey J., Alexander A., et al. Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4. J Clin Invest 104 (1999) 1449-1457
17. Viner N.J., Nelson C.A., Deck B., and Unanue E.R. Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing. J Immunol 156 (1996) 2365-2368